MedWatch 3500A: The MoCRA Adverse Event Reporting Deadline Explained

MoCRA section 605 requires the responsible person for a cosmetic product to report serious adverse events to FDA within 15 business days of becoming aware of them. The required form is MedWatch 3500A — the same form pharmaceutical companies use for drug adverse events, adapted for cosmetic reporting.

This guide walks through what counts as a serious adverse event, exactly when the 15-business-day clock starts, what data 3500A requires, and how to submit.

What is a "serious adverse event"?

MoCRA imports the definition from the Federal Food, Drug, and Cosmetic Act. A serious adverse event is one where the use of a cosmetic product results in:

Death
A life-threatening experience
Inpatient hospitalization
A persistent or significant disability or incapacity
A congenital anomaly or birth defect
An infection
Significant disfigurement (including any one of: significant hair loss, persistent or significant alteration of appearance, other than as intended, under conditions of use that are customary or usual)
An event requiring a medical or surgical intervention based on a reasonable medical judgment to prevent any of the outcomes listed above

Note the breadth: "significant disfigurement" includes significant hair loss. The FDA-issued November 2023 guidance interprets this strictly — a single substantiated hair-loss case from a chemical hair relaxer or smoothing product is reportable.

When the 15-business-day clock starts

The clock starts when the responsible person becomes aware of the adverse event. "Becomes aware" includes:

A consumer reporting the event to your customer service
A retailer forwarding a consumer complaint
A medical professional contacting your medical affairs function
An adverse event posted on a public review platform that your social listening team flags
A health department or competent authority contacting you

Business days means Monday-Friday excluding federal holidays. A complaint received Friday afternoon does not reach day 1 until Monday. A complaint received the day before Thanksgiving has a longer effective window than a complaint received on a Monday in spring.

Cosmetica's adverse event tracker handles business-day arithmetic automatically — including federal holidays — so the deadline date is always explicit.

What MedWatch 3500A requires

The form has seven sections. For cosmetic reporting, the relevant fields are:

Section A — Patient information

Demographics: age, sex (optional), weight (optional). Patient identifier (case number; can be a brand-assigned ID rather than personal information).

Section B — Adverse event or product problem

Description of what happened in the patient's own words where possible. Date of event, date of report. Outcome — which of the "serious" categories applies. Whether medical intervention was required.

Section C — Suspect product

Product name, manufacturer, NDC or product identifier (use your MoCRA listing ID), lot/batch number where known, dose/frequency of use, route of administration (typically topical), date and duration of use.

Section D — Suspect medical device

Not applicable for most cosmetics. Skip.

Section E — Initial reporter

Name, address, profession of the person who initially reported the event (the consumer, the medical professional, etc.). Can be anonymized as a case identifier.

Section F — All manufacturers

Your company's name and address as the responsible person. NDA/IND/BLA fields can be blank for cosmetics. Manufacturer report number — a sequential identifier you assign.

Section G — Mandatory reporter

Indicate whether this is an initial or follow-up report. Date you became aware of the event. Information about the source.

How to submit

FDA accepts MedWatch 3500A submissions for cosmetic adverse events via email to CosmeticAERS@fda.hhs.gov. The completed form should be attached as a PDF. Subject line conventions matter — FDA's processing system parses subject lines for routing:

Subject: MoCRA AER - [Brand] - [Internal Case ID] - [Initial|Follow-up]

FDA will email back an acknowledgement with an FDA-assigned case number, typically within several business days. Keep that acknowledgement on file as proof of timely submission.

Record retention

You must retain all records related to the adverse event for 6 years from the date of the event. This includes:

The original complaint and any follow-up communications
Internal investigation notes
Copies of the submitted MedWatch 3500A
FDA's acknowledgement and any follow-up correspondence
Any product testing performed in response to the complaint

FDA can request these records during an inspection or compliance investigation. Cosmetica's adverse event module stores all related artifacts together and exports a complete record package for any individual case.

Common mistakes

Treating non-serious events as serious. Mild irritation that resolves without medical intervention is not reportable. Don't over-report — it dilutes FDA's signal detection and creates unnecessary work.
Treating the 15-day deadline as calendar days. It's business days. Confirm using a federal-holiday-aware calendar.
Reporting without internal investigation. The initial report can be brief, but if you have time before day 15, including investigation findings is more useful to FDA. Follow-up reports are encouraged when new information emerges.
Forgetting record retention. 6 years from the event date — even after FDA closes its file on the case.

How Cosmetica automates this

Cosmetica's adverse event tracker:

Lets you log incoming complaints from any channel (email, phone, retailer, social listening) with a single intake form.
Categorizes each complaint by likelihood of meeting "serious adverse event" criteria and flags borderline cases for review.
Calculates the 15-business-day deadline based on the date of awareness, accounting for federal holidays.
Generates a completed MedWatch 3500A PDF from your complaint data.
Submits the form to CosmeticAERS@fda.hhs.gov via AWS SES with the correct subject line format.
Stores the submission, FDA acknowledgement, and all related artifacts in a 6-year retention archive.

See Cosmetica's MoCRA coverage → | What is MedWatch 3500A? →